Company intelligence / Profile preview

LiveKidney.Bio

Tel Aviv-Jaffa, Central District, Israellivekidney.bio ↗

Ownership: Private
Employees: ~10
Development stage: Phase 2

Overview

LiveKidney.Bio is developing a proprietary hydrogel-based delivery system for advanced cell-based therapies targeting kidney diseases. Their lead program uses umbilical cord-derived mesenchymal stromal cells to treat lupus nephritis and CKD. The company has progressed from in vitro and animal studies to clinical trials, with at least one program in Phase 2 as of 2024. Early results suggest potential safety and efficacy, aiming to prevent progression toward kidney failure and improve comorbidities such as diabetes, hypertension, and obesity.[1][5][7]

Therapeutic areas: ImmunologyNephrology
Modalities: Cell therapies (Mesenchymal stem cell therapy, specifically umbilical cord-derived MSCs)[1][8]Extracellular vesicles (EVs)[1]
Industry: Biotech

Drug pipeline

2 assets

LK-02

Preclinical

1 more asset in the full pipeline.

Request access →

Partnerships

Mayo Clinic[1]Medical University of South Carolina[1]Isotopia Global – manufacturing partnership for lupus nephritis therapy component production[5][7]

Beyond the preview

Go deeper on LiveKidney.Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LiveKidney.Bio.

Explore the full profile